Voice problems / hoarseness

Definition/Description

Dysphonia - an abnormal voice.

Hoarseness - change in quality of voice and difficulty in projecting the voice (with or without the need to clear the voice or throat regularly).


Features of a normal voice include: clarity, consistency, audibility, stamina, flexibility of pitch and is comfortable. A patient may complain of problems with any of these features.

Red Flag Symptoms

Persistent hoarse voice for more than six weeks with no history of URTI is a 2WW referral (exclude lung cancer)
  • Continuous hoarse voice rather than an intermittent hoarse voice.
  • Any signs of airway obstruction (such as stridor)
  • Dysphagia (difficulties swallowing) or odynophagia (painful swallowing)
  • Frequent associated cough with or without sickness / bringing up food boli
  • Haemoptysis
  • Consider the possible significance of risk factors, including:
    • age – over 50 years
    • smoking
    • excess alcohol intake.

The recurrent laryngeal nerve extends deep into the chest, therefore a CXR would be indicated for probably most patients (certainly smokers; others if middle aged) before a referral to ensure no pathology there.

Guidelines on Management

  • Explore possible strain and overuse (public speaking, teaching, singing etc.).
  • Does resting the voice help?
  • Could this be laryngitis after an URTI (can last for 2-3 weeks)
  • Could this be dyspepsia or silent reflux (voice problems often worse in the morning, better during the day)
  • Particularly in asthmatic patients on steroid inhalers: think possible fungal infection in the upper airway
  • For localized or mild oral candidal infection, prescribe topical treatment for 7 days (and advise the person to continue treatment for 2 days after symptoms resolve).
    • Offer miconazole oral gel first-line.
    • Offer nystatin suspension if miconazole is unsuitable.
    • For extensive or severe candidiasis, prescribe oral fluconazole 50 mg a day for 7 days.
  • Advise on prevention – brush teeth/ rinse mouth after inhaler use.

Less common other causes for voice changes or hoarseness: nerve palsy, hypothyroidism, Parkinsonism or medication side effects (e.g. antihypertensives – particularly ACEi, antihistamines, antidepressants, contraceptives etc) and others.
 

Good advice to give patients includes:

  • rest the voice as much as possible
  • avoid whispering (this actually strains the voice box more than normal use)
  • reduce or stop negative impacts on the voice box (smoking, alcohol, caffeine, dryness, spicy food etc.)
  • ensure sufficient regular voice lubrication (e.g. sips of clear fluid, sugar-free lozenges, simple steam inhalations)

Consider a trial of Peptac® +/- a PPI for one month in suspected possible (silent) reflux.

Referral Criteria/Information

Emergency or 2WR: 

  • Acute stridor – refer immediately.
  • Continuous hoarse voice for more than two or three weeks, particularly if there are individual risk factors (age, smoking, alcohol excess etc.), as mentioned above.
     

Routine:

  • If conservative measures are ineffective and there is a possible need for a laryngoscopy and/or speech therapy.
  • If it is a low-risk but possibly anxious patient, the ENT primary care clinic (which is bookable via the on-call SHO) could provide a nasal endoscopy facility for quick reassurance.
     

Information to include in referral letter:

  • Is it hoarseness or dysphonia or a mixed picture?
  • Are there any patterns or is it a continuum?
  • Time line and possible initial cause and/or maintaining factors.
  • Routine bloods including TFTs, CXR when indicated
  • Relevant past medical / surgical history
  • Current regular medication; have you trialed a course of Peptac® +/- PPI
  • BMI / Smoking status / Alcohol status / Employment.
     

Investigations prior to referral

  • CXR - exclude sinister non-ENT causes when indicated.
  • Baseline bloods including TFTs

Additional Resources & Reference

Patient Information Leaflets/ PDAs

http://patient.info/health/laryngitis-leaflet 
 

References

Minor update 2/12/20 to align with 2WW form Shaun O’Connell

Places covered by

  • vale-of-york

Hospital Trusts

  • york-and-scarborough-teaching-hospitals
Author: Responsible GP: Dr Tillmann Jacobi / Responsible Consultant: Mr Frank Agada / Responsible Pharmacist: Laura Angus
Date created: 12/08/2025, 09:57
Last modified: 12/08/2025, 10:37
Date of review: 30/9/24